(Q46783215)

25 December 2017

title

Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase (English)

1 reference

25 December 2017

author name string

Hideki Fujino

1

1 reference

25 December 2017

Tsuyoshi Saito

2

1 reference

25 December 2017

Shin-Ichiro Ogawa

3

1 reference

25 December 2017

Junji Kojima

4

1 reference

25 December 2017

publication date

1 October 2005

1 reference

25 December 2017

Journal of Pharmacy and Pharmacology

published in

1 reference

25 December 2017

volume

57

1 reference

25 December 2017

issue

10

1 reference

25 December 2017

page(s)

1305-1311

1 reference

25 December 2017

Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Triglyceride-lowering effect of pitavastatin [corrected] in a rat model of postprandial lipemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase--effect of cMOAT deficiency on hepatobiliary excretion in rats and of mdr1a/b gene disruption on tissue distribution in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Clinical pharmacokinetics of cerivastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Uptake mechanism of pitavastatin, a new inhibitor of HMG-CoA reductase, in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.57.10.0009

21 January 2018

Identifiers

DOI

10.1211/JPP.57.10.0009

1 reference

25 December 2017

1 reference

25 December 2017